Bharat Biotech Submits Phase-1 Trial Data of 'Game Changer' Intranasal Covid Vaccine
The company sought permission from the drug regulator for a change from nasal drop to spray; expert panel advised both drop and spray be used for clinical trials.
from Top India News- News18.com https://ift.tt/2SZUXFp
via IFTTT
from Top India News- News18.com https://ift.tt/2SZUXFp
via IFTTT
No comments